Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research
In Their Words

Education and Training

  • Fellow In Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow In Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.D., Duke University, 1993

Publications

Oloruntoba, OO, Wilder, JM, Smith, AD, Muir, AJ, and Moylan, CA. "The Influence of Race on Patient Preferences and Access to Orthotopic Liver Transplantation and Organ Donation." 2014.

Scholars@Duke

Jensen, DM, O'Leary, JG, Pockros, PJ, Sherman, KE, Kwo, PY, Mailliard, ME, Kowdley, KV, Muir, AJ, Dickson, RC, Ramani, A, Manns, MP, Lok, AS, Akuskevich, L, Nelson, DR, and Fried, MW. "Safety and Efficacy of Sofosbuvir-Containing Regimens for Hepatitis C: Real-World Experience in a Diverse, Longitudinal Observational Cohort." 2014.

Scholars@Duke

Jeffers, LJ, Wilder, JM, Muir, AJ, Howell, C, Zhu, Y, Seyedkazemi, S, Yang, JC, Pang, PS, McHutchison, JG, and Reddy, KR. "Safety and Efficacy of Ledipasvir/Sofosbuvir Single-Tablet-Regimen in African Americans with Genotype 1 Chronic Hepatitis C Virus: A Retrospective Analysis of Phase 3 Studies." 2014.

Scholars@Duke

Jou, JH, Beste, LA, Yang, Y, Chang, MF, and Muir, AJ. "Specialty Care is Associated with Early Diagnosis of Hepatitis C-related Hepatocellular Carcinoma in US Veterans." 2014.

Scholars@Duke

Clark, PJ, Aghemo, A, Degasperi, E, Galmozzi, E, Urban, TJ, Vock, DM, Patel, K, Thompson, AJ, Rumi, MG, D'Ambrosio, R, Muir, AJ, and Colombo, M. "Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy." Journal of Viral Hepatitis 20, no. 12 (December 1, 2013): 858-866.

Full Text

Charlton, MR, Gane, EJ, Manns, MP, Brown, RS, Curry, MP, Kwo, PY, Fontana, RJ, Gilroy, R, Teperman, LW, Muir, AJ, McHutchison, JG, Symonds, WT, Denning, JM, McNair, L, Arterburn, S, Terrault, N, Samuel, D, and Forns, X. "Sofosbuvir and Ribavirin for the Treatment of Established Recurrent Hepatitis C Infection After Liver Transplantation: Preliminary Results of a Prospective, Multicenter Study." December 2013.

Scholars@Duke

Jou, JH, Sulkowski, MS, Noviello, S, Long, J, Pedicone, LD, McHutchison, JG, and Muir, AJ. "Analysis of site performance in academic-based and community-based centers in the IDEAL Study." J Clin Gastroenterol 47, no. 10 (November 2013): e91-e95.

PMID
23787248
Full Text

Jazwinski, AB, Clark, PJ, Thompson, AJ, Gordon, SC, Lawitz, EJ, Noviello, S, Brass, CA, Pedicone, LD, Albrecht, JK, Sulkowski, MS, and Muir, AJ. "Predictors of consent to pharmacogenomics testing in the IDEAL study." PHARMACOGENETICS AND GENOMICS 23, no. 11 (November 2013): 619-623.

Full Text

Afdhal, NH, Zeuzem, S, Schooley, RT, Thomas, DL, Ward, JW, Litwin, AH, Razavi, H, Castera, L, Poynard, T, Muir, A, Mehta, SH, Dee, L, Graham, C, Church, DR, Talal, AH, Sulkowski, MS, and Jacobson, IM. "The new paradigm of hepatitis C therapy: Integration of oral therapies into best practices." Journal of Viral Hepatitis 20, no. 11 (October 18, 2013): 745-760. (Review)

PMID
24168254
Full Text

Muir, AJ, Jurkowski, C, Cooney, EL, Hillson, JL, Lataillade, M, Casullo, VM, Gray, T, Xu, D, Yogendran, L, and Srinivasan, S. "Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies." October 2013.

Scholars@Duke

Pages